Recent increase in Candida auris frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization.

Abstract excerpt

We observed an increase in the frequency of Candida auris among invasive candidiasis isolates in the 2022 SENTRY Antifungal Surveillance Program compared to prior years: ≤0.1% before 2018, 0.4%-0.6% from 2018 to 2021, and 1.6% in 2022. C. auris isolates were collected in seven countries, but 28 (35.9%) isolates were recovered in the USA (five states; more common in New York, Texas, and New Jersey) and 26 (33.3%)...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Amphotericin B
• Share to Antifungal Agents